Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / First Trust NYSE(R) Arca(R) Biotechnology Index Fund
-
Shares outstanding
-
11,300,576
-
Total 13F shares
-
3,143,605
-
Share change
-
-303,837
-
Total reported value
-
$540,228,542
-
Price per share
-
$171.93
-
Number of holders
-
252
-
Value change
-
-$50,274,497
-
Number of buys
-
83
-
Number of sells
-
119
Institutional Holders of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) as of Q3 2024
As of 30 Sep 2024,
First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) was held by
252 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,143,605 shares.
The largest 10 holders included
MORGAN STANLEY, UBS Group AG, WELLS FARGO & COMPANY/MN, LPL Financial LLC, Royal Bank of Canada, Berger Financial Group, Inc, ENVESTNET ASSET MANAGEMENT INC, Raymond James Financial Services Advisors, Inc., RAYMOND JAMES & ASSOCIATES, and D.A. DAVIDSON & CO..
This page lists
252
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.